First Interstate Bank lowered its stake in UnitedHealth Group Inc. (NYSE:UNH) by 42.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 63,765 shares of the healthcare conglomerate’s stock after selling 46,093 shares during the period. UnitedHealth Group accounts for approximately 1.9% of First Interstate Bank’s investment portfolio, making the stock its 14th largest position. First Interstate Bank’s holdings in UnitedHealth Group were worth $9,004,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. MCF Advisors LLC raised its stake in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 238 shares during the last quarter. Feltz Wealth PLAN Inc. bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $143,000. Benjamin F. Edwards & Company Inc. increased its position in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock valued at $153,000 after buying an additional 518 shares during the last quarter. Finally, Evanson Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $201,000. Institutional investors and hedge funds own 85.94% of the company’s stock.

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.19% on Tuesday, hitting $137.42. 1,075,501 shares of the company were exchanged. The company has a 50 day moving average price of $139.17 and a 200-day moving average price of $134.99. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48. The stock has a market capitalization of $130.88 billion, a P/E ratio of 21.51 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. On average, equities analysts expect that UnitedHealth Group Inc. will post $7.92 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th will be issued a $0.625 dividend. The ex-dividend date of this dividend is Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.

Several brokerages recently commented on UNH. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $161.00 price objective (up previously from $145.00) on shares of UnitedHealth Group in a research note on Friday, July 22nd. Barclays PLC increased their price objective on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Citigroup Inc. increased their price objective on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research note on Friday, July 22nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a research note on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $154.96.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.65% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.